A significant milestone for Sekkei Bio to receive project support from the Bill & Melinda Gates Foundation.

This grant will enable them to leverage their proprietary circular RNA (C3 RNA) platform in developing a stable and cost-effective RNA-based RSV vaccine candidate. The purpose of the grant is to generate probe molecules to interrogate complex reproductive biology processes that could help further validate potential nonhormonal contraceptive targets.

To generate probe molecules to interrogate complex reproductive biology processes that could help further validate potential nonhormonal contraceptive targets.